| Value | ₹0.03 Cr |
|---|
BSE filing, NSE: ANURAS. Summary written from the filing by ALFA Finder's alert engine.
Anupam Rasayan India Ltd: key numbers
- Share price
- ₹1,151.40
- Market cap
- ₹13,109 Cr
- Revenue (annual)
- ₹2,365 Cr
- Net profit (annual)
- ₹170.1 Cr
- P/E (TTM)
- 75.0×Sector 34.1×
- Promoter holding
- 59.07%+0.00% QoQ
- FII holding
- 8.65%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Anupam Rasayan India Ltd
All →Anupam Rasayan India Annual General Meeting
Anupam Rasayan India Limited filed copy of minutes of its Annual General Meeting held on September 30, 2026. The filing is procedural and carries no financial or business event.
Anupam Rasayan India Other Announcement
Anupam Rasayan India disclosed a Crisil ESG rating of 62 and Core ESG rating of 63 (Strong). No transaction or business decision is involved.
Anupam Rasayan India Share Pledge
Catalyst Trusteeship Ltd, as Debenture Trustee, received pledge on 24,62,215 shares of Anupam Rasayan India. Encumbered stake rose from 14.90% to 17.07% of total capital.
Anupam Rasayan India Share Pledge
Promoter Mona Anandbhai Desai created and released pledges on shares securing ₹578 Crore subsidiary debt. Net 14,60,625 shares (1.28%) remain encumbered post-transactions.
- Value
- ₹578.0 Cr
Anupam Rasayan India Share Pledge
Anupam Rasayan India Ltd promoters Anand Sureshbhai Desai and Shraddha Anand Desai pledged 1,20,41,160 equity shares. The pledge serves as security for debt obligations and loans.
- Value
- ₹145.0 Cr
Anupam Rasayan India Acquisition
Anupam Rasayan corrected its previous disclosure regarding the acquisition of Bliss GVS Pharma Limited, clarifying the share counts acquired by the company and its PAC.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date